Orgenesis Stock Market Outlook
| ORGS Stock | USD 0.55 0.39 243.75% |
Slightly above 53% of Orgenesis' investor base is interested to short. The analysis of overall sentiment of trading Orgenesis pink sheet suggests that many investors are impartial at this time. Orgenesis' investing sentiment can be driven by a variety of factors including economic data, Orgenesis' earnings reports, geopolitical events, and overall market trends.
Comfort Level 47
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Orgenesis' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Orgenesis.
News SentimentNeutral | Hype SentimentNeutral | Insider SentimentWaiting |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Orgenesis is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Orgenesis given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Orgenesis, the advice is generated through an automated system that utilizes algorithms and statistical models.
Execute Orgenesis Advice
The Orgenesis recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Orgenesis. Macroaxis does not own or have any residual interests in Orgenesis or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Orgenesis' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Solid | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Moderate | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon Orgenesis has a Mean Deviation of 66.49, Semi Deviation of 30.45, Standard Deviation of 107.1, Variance of 11470.89, Downside Variance of 2721.42 and Semi Variance of 927.18We provide trade recommendations to complement the recent expert consensus on Orgenesis. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Orgenesis is not overpriced, please check all Orgenesis fundamentals, including its price to book, current ratio, retained earnings, as well as the relationship between the net income and target price . As Orgenesis appears to be a penny stock we also advise to check out its price to earning numbers.
Orgenesis Trading Alerts and Improvement Suggestions
| Orgenesis is way too risky over 90 days horizon | |
| Orgenesis has some characteristics of a very speculative penny stock | |
| Orgenesis appears to be risky and price may revert if volatility continues | |
| Orgenesis has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 530 K. Net Loss for the year was (64.92 M) with profit before overhead, payroll, taxes, and interest of 36.02 M. | |
| Orgenesis currently holds about 2.3 M in cash with (14.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
Orgenesis Returns Distribution Density
The distribution of Orgenesis' historical returns is an attempt to chart the uncertainty of Orgenesis' future price movements. The chart of the probability distribution of Orgenesis daily returns describes the distribution of returns around its average expected value. We use Orgenesis price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Orgenesis returns is essential to provide solid investment analysis for Orgenesis.
| Mean Return | 25.31 | Value At Risk | -75.71 | Potential Upside | 341.18 | Standard Deviation | 77.50 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Orgenesis historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Orgenesis Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Orgenesis or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Orgenesis' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Orgenesis pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 26.22 | |
β | Beta against Dow Jones | -9.88 | |
σ | Overall volatility | 102.44 | |
Ir | Information ratio | 0.24 |
Orgenesis Volatility Alert
Orgenesis is showing large volatility of returns over the selected time horizon. Orgenesis is a potential penny stock. Although Orgenesis may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Orgenesis. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Orgenesis instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Orgenesis Fundamentals Vs Peers
Comparing Orgenesis' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Orgenesis' direct or indirect competition across all of the common fundamentals between Orgenesis and the related equities. This way, we can detect undervalued stocks with similar characteristics as Orgenesis or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Orgenesis' fundamental indicators could also be used in its relative valuation, which is a method of valuing Orgenesis by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Orgenesis to competition |
| Fundamentals | Orgenesis | Peer Average |
| Return On Equity | -7.27 | -0.31 |
| Return On Asset | -0.3 | -0.14 |
| Operating Margin | (16.54) % | (5.51) % |
| Current Valuation | 23.01 M | 16.62 B |
| Shares Outstanding | 4.77 M | 571.82 M |
| Shares Owned By Insiders | 21.16 % | 10.09 % |
| Shares Owned By Institutions | 4.54 % | 39.21 % |
| Number Of Shares Shorted | 56.25 K | 4.71 M |
| Price To Earning | 7.52 X | 28.72 X |
| Price To Book | 1.26 X | 9.51 X |
| Price To Sales | 15.21 X | 11.42 X |
| Revenue | 530 K | 9.43 B |
| Gross Profit | 36.02 M | 27.38 B |
| EBITDA | (54.07 M) | 3.9 B |
| Net Income | (64.92 M) | 570.98 M |
| Cash And Equivalents | 2.3 M | 2.7 B |
| Cash Per Share | 0.09 X | 5.01 X |
| Total Debt | 22.62 M | 5.32 B |
| Debt To Equity | 0.64 % | 48.70 % |
| Current Ratio | 1.57 X | 2.16 X |
| Book Value Per Share | (3.30) X | 1.93 K |
| Cash Flow From Operations | (14.84 M) | 971.22 M |
| Short Ratio | 2.39 X | 4.00 X |
| Earnings Per Share | (8.00) X | 3.12 X |
| Target Price | 6.0 | |
| Number Of Employees | 146 | 18.84 K |
| Beta | 1.21 | -0.15 |
| Market Capitalization | 10.07 M | 19.03 B |
| Total Asset | 14.55 M | 29.47 B |
| Retained Earnings | (176.62 M) | 9.33 B |
| Working Capital | (12.33 M) | 1.48 B |
| Current Asset | 5.29 M | 9.34 B |
| Current Liabilities | 14.92 M | 7.9 B |
Note: Acquisition by Safier Jacob of 3000 shares of Orgenesis at 0.5421 subject to Rule 16b-3 [view details]
Orgenesis Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Orgenesis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 3.44 | |||
| Day Median Price | 0.55 | |||
| Day Typical Price | 0.55 | |||
| Price Action Indicator | 0.2 | |||
| Period Momentum Indicator | 0.39 |
About Orgenesis Buy or Sell Advice
When is the right time to buy or sell Orgenesis? Buying financial instruments such as Orgenesis Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Orgenesis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Blend Funds Thematic Idea Now
Large Blend Funds
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Orgenesis Pink Sheet Analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.